Citation Impact
Citing Papers
Sphingosine but not Sphingosine-1-phosphate Stimulates Suicidal Erythrocyte Death
2011
Overexpression of ErbB2 Blocks Taxol-Induced Apoptosis by Upregulation of p21Cip1, which Inhibits p34Cdc2 Kinase
1998
Improved effectiveness of nanoparticle albumin-bound (nab) paclitaxel versus polysorbate-based docetaxel in multiple xenografts as a function of HER2 and SPARC status
2008
Physiology and Pathophysiology of Eryptosis
2012
Ceramide in Suicidal Death of Erythrocytes
2010
A Polymer-Based, Paclitaxel-Eluting Stent in Patients with Coronary Artery Disease
2004 Standout
Mechanical stress reduces podocyte proliferation in vitro
2002
Integrins in cancer: biological implications and therapeutic opportunities
2009 Standout
Fatty acid synthase and the lipogenic phenotype in cancer pathogenesis
2007 Standout
An mTORC1-to-CDK1 Switch Maintains Autophagy Suppression during Mitosis
2019
Anti-tumor activity of calcitriol: pre-clinical and clinical studies
2004
Anthracyclines: Molecular Advances and Pharmacologic Developments in Antitumor Activity and Cardiotoxicity
2004 Standout
Rationale for the treatment of solid tumors with the proteasome inhibitor bortezomib
2003
Cyclotherapy: Protection of Normal Cells and Unshielding of Cancer Cells
2002
Genistein arrests hepatoma cells at G2/M phase: involvement of ATM activation and upregulation of p21waf1/cip1 and Wee1
2003
AKT/PKB Phosphorylation of p21Cip/WAF1 Enhances Protein Stability of p21Cip/WAF1 and Promotes Cell Survival
2002
Estimation of optimal serum concentrations of 25-hydroxyvitamin D for multiple health outcomes
2006 Standout
Medicinal mushroom modulators of molecular targets as cancer therapeutics
2005 Standout
Tie2/Angiopoietin-1 Signaling Regulates Hematopoietic Stem Cell Quiescence in the Bone Marrow Niche
2004 Standout
Proteasome Inhibitors in the Treatment of B-Cell Malignancies
2002
mTOR at the nexus of nutrition, growth, ageing and disease
2020 Standout
Differentiation therapy of human cancer: basic science and clinical applications
2001
Stuck in Division or Passing through
2004
The Cyclin-Ubiquitin Ligase Activity of Cyclosome/APC Is Jointly Activated by Protein Kinases Cdk1-Cyclin B and Plk
2002 StandoutNobel
Medicinal chemistry and pharmacology of genus Tripterygium (Celastraceae)
2007 Standout
p21 in cancer: intricate networks and multiple activities
2009 Standout
Coumarins: Old Compounds with Novel Promising Therapeutic Perspectives
2010 Standout
Transfusion reactions: prevention, diagnosis, and treatment
2016
Translation of new cancer treatments from pet dogs to humans
2008 Standout
Integrin signaling inhibits paclitaxel-induced apoptosis in breast cancer cells
2001
Sickle-cell disease
2010 Standout
Tanshinone IIA, an isolated compound from Salvia miltiorrhiza Bunge, induces apoptosis in HeLa cells through mitotic arrest
2008
PI3K/Akt signalling pathway and cancer
2003 Standout
The ubiquitin system: pathogenesis of human diseases and drug targeting
2004 StandoutNobel
A Beginner's Guide to NF‐κB Signaling Pathways
2004
Pharmacological and small interference RNA‐mediated inhibition of breast cancer‐associated fatty acid synthase (oncogenic antigen‐519) synergistically enhances Taxol (paclitaxel)‐induced cytotoxicity
2005
Low concentrations of paclitaxel induce cell type-dependent p53, p21 and G1/G2 arrest instead of mitotic arrest: molecular determinants of paclitaxel-induced cytotoxicity
2001
Potential for proteasome inhibition in the treatment of cancer
2003
Endocytosis of nanomedicines
2010 Standout
Age Sensitivity of NFκB Abundance and Programmed Cell Death in Erythrocytes Induced by NFκB Inhibitors
2013 Standout
Mechanisms and pathophysiological significance of eryptosis, the suicidal erythrocyte death
2015 Standout
The spindle-assembly checkpoint in space and time
2007 Standout
Differential expression of cyclin-dependent kinase inhibitors in human glomerular disease: Role in podocyte proliferation and maturation
2000
Guidelines on the Use of Therapeutic Apheresis in Clinical Practice – Evidence‐Based Approach from the Writing Committee of the American Society for Apheresis: The Eighth Special Issue
2019 Standout
Transfusion thresholds and other strategies for guiding allogeneic red blood cell transfusion
2016 Standout
Constituents from Salvia Species and Their Biological Activities
2012 Standout
Cell Biology of the Glomerular Podocyte
2003 Standout
Fasting and cancer treatment in humans: A case series report
2009 Standout
Expression and Significance of p53, Rb, p21/waf-1, p16/ink-4a, and PTEN Tumor Suppressors in Canine Melanoma
2002
Immunohematologic tolerance of chronic transfusion exchanges with erythrocytapheresis in sickle cell disease
2014
HER2 (neu) Signaling Increases the Rate of Hypoxia-Inducible Factor 1α (HIF-1α) Synthesis: Novel Mechanism for HIF-1-Mediated Vascular Endothelial Growth Factor Expression
2001 StandoutNobel
THE MAMMALIAN UNFOLDED PROTEIN RESPONSE
2005 Standout
Delayed hemolytic transfusion reaction in children with sickle cell disease
2011
Transfusion therapy for sickle cell disease: a balancing act
2013
Hyperhemolysis syndrome in patients with sickle cell anemia: report of three cases
2015
Red blood cell alloimmunization in sickle cell disease: pathophysiology, risk factors, and transfusion management
2012
Probing the Dynamics and Functions of Aurora B Kinase in Living Cells during Mitosis and Cytokinesis
2002
Works of Philippe Chadebech being referenced
Involvement of p21 in the PKC‐induced regulation of the G2/M cell cycle transition
1999
Rituximab for prevention of delayed hemolytic transfusion reaction in sickle cell disease
2007
Involvement of p21 in mitotic exit after paclitaxel treatment in MCF-7 breast adenocarcinoma cell line
1997
Phosphorylation and Proteasome-Dependent Degradation of Bcl-2 in Mitotic-Arrested Cells after Microtubule Damage
1999
Delayed hemolytic transfusion reaction in sickle cell disease patients: evidence of an emerging syndrome with suicidal red blood cell death
2009
The use of rituximab to prevent severe delayed haemolytic transfusion reaction in immunized patients with sickle cell disease
2014
IgA-mediated human autoimmune hemolytic anemia as a result of hemagglutination in the spleen, but independent of complement activation and FcαRI
2010
Up-regulation of cdc2 protein during paclitaxel-induced apoptosis
2000